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Background: Digital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of
free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global
public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate
product that may in fact be counterfeit or substandard. These cybercriminal actors exploit available eDTCA
mediums over the Internet to market their suspect products globally. Despite these risks, a detailed assessment of
the public health, patient safety, and cybersecurity threats and governance mechanisms to address them has not
been conducted.
Discussion: Illicit online pharmacies represent a significant global public health and patient safety risk. Existing
governance mechanisms are insufficient and include lack of adequate adoption in national regulation, ineffective
voluntary governance mechanisms, and uneven global law enforcement efforts that have allowed proliferation of
these cybercriminals on the web. In order to effectively address this multistakeholder threat, inclusive global
governance strategies that engage the information technology, law enforcement and public health sectors should
be established.
Summary: Effective global “eHealth Governance” focused on cybercrime is needed in order to effectively combat
illicit online pharmacies. This includes building upon existing Internet governance structures and coordinating
partnership between the UN Office of Drugs and Crime that leads the global fight against transnational organized
crime and the Internet Governance Forum that is shaping the future of Internet governance. Through a UNODC-IGF
governance mechanism, investigation, detection and coordination of activities against illicit online pharmacies and
their misuse of eDTCA can commence.
Keywords: Internet governance, Online pharmacies, Direct-to-consumer advertising, Global health, Social media,
Counterfeit medicines, CybercrimeBackground
Health-related technologies are undergoing an evolution
driven by the rapid emergence and dominance of the
Internet in everyday life. According to the International
Telecommunications Union (“ITU”), an estimated 2.7
billion people (39% of the world’s population) are online in
2013 [1]. These online users are increasingly becoming* Correspondence: tmackey@ucsd.edu
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distribution, and reproduction in any mediumhealth information seekers and consumers. A recent Pew
Internet survey found that 72% of USA adult online users
search for health and medical information online and ap-
proximately 1/3rd engage in self-diagnosing of their health
problems [2]. This trend is not solely limited to the USA,
with recent surveys indicating one in two Internet users, in
a diverse collection of 12 different countries, also engage in
self-diagnosing [3].
This growth has led to the development of new con-
cepts in health, including “e-Health”, i.e., a multidiscip-
linary “intersection of medical informatics, public health
and business, referring to health services and information
delivered or enhanced through the Internet and relatedentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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2.0” is used to describe interactive social network and
consumer-directed use of health-related applications,
services, and tools [5]. e-Health developments have
highlighted the benefits of these technologies with an
emphasis on their potential to improve health education,
outreach, disease surveillance, collaboration, communi-
cation between patients and providers, and support of
clinical decision-making [5-11]. In turn, these benefits
can result in improved access and delivery of healthcare
services (including in low-income and rural settings),
reduced associated healthcare costs, and better health out-
comes through technology investment [5-11]. Consequen-
tially, although challenges remain for its full potential to be
realized, e-Health technologies are expanding in global
adoption [7,9,12].
Yet, e-Health advances also enable health-related digital
marketing and promotion that can be of questionable
quality, reliability, origin and authenticity [13-15]. General
advocacy for free and open information exchange that is
self-governed has led to lack of adequate Internet govern-
ance. This consequently has given rise to the globalization
of pharmaceutical marketing and forms of digital direct-
to-consumer advertising (“eDTCA”) as they evolve with
Internet technologies [16,17]. However, it is important to
note that direct-to-consumer advertising (“DTCA”) is only
legally permitted in the USA and New Zealand among de-
veloped countries, yet DTCA and eDTCA transmission
via the Internet and other mediums has been shown to
cross geopolitical borders and pose unaddressed regula-
tory and public health problems [17,18]. Though online
health information has potential utility if properly filtered,
vetted, and framed within eHealth literacy needs, studies
have demonstrated that quality of online health informa-
tion (including pharmaceutical marketing) can be highly
uneven as it is largely unregulated [15].
Perhaps most disturbing, vulnerabilities in the current
global Internet governance and the pharmaceutical promo-
tion regulatory regime provides fertile ground for promo-
tion of dangerous medicines by illicit, or “rogue” online
pharmacies [19,20]. Illicit online pharmacies market the
sale of purportedly safe, legitimate product that may in fact
be counterfeit or of substandard quality [15,19-21]. This
activity should not be conflated with the global debate over
the appropriate definition of “counterfeit” medicines, which
is currently mired in considerations involving intellectual
property rights and access to medicines [22]. For purposes
of clarity, we adopt the general standard that counterfeit
medicines consist of those (a) deliberately produced with
substandard quality; (b) those fraudulently labeled with
respect to their identity/origin; or (c) that are otherwise
tainted, adulterated, or made ineffective or harmful [22].
Illicit cyberpharmacies that sell questionable medica-
tions without a prescription hence, represent a form ofcybercrime that has been described as the preeminent
global governance challenge of the 21st century [23]. In
fact, illicit online pharmacies represent a dual threat in
that they present both challenges to global public health
and risks to global cybersecurity that remain largely un-
addressed by international stakeholders [19,20]. Enabling
this digital trade are online criminal actors that exploit
eDTCA mediums intended for use by legal actors (but
possibly illegal in jurisdictions that do not permit DTCA
marketing) to drive sales of their potentially dangerous
services and products [13,17].
Given these ongoing public safety concerns that inter-
sect between the global health and information technol-
ogy (“IT”) policy domains, it is essential to examine the
mechanisms and infrastructures utilized by illicit online
pharmacies to determine needed strategies in combating
this unique form of transnational cybercrime. Conse-
quently, we first describe the potential public health
risks, patient safety dangers, and cyber security issues asso-
ciated with illicit online pharmacies. On this basis, we also
review key efforts by a variety of actors in the international
community attempting to address this issue. Finally, we
propose a novel global governance approach emphasizing
public health priorities in current Internet governance ac-
tivities as a foundation to combat illicit online pharmacies
and their exploitation of unregulated eDTCA.
Patient safety risks of illicit online pharmacies
Several studies have explored the public health implications
of industry-based legally-allowable DTCA. Possible negative
consequences include dissemination of misleading or un-
balanced information about the risks and benefits of medi-
cations, overutilization of expensive prescription drugs,
aggressive promotion of pharmaceuticals with questionable
safety profiles often at early stages in their product life-
cycle, and negative patient-physician interactions [24-29].
Yet eDTCA use by illicit online pharmacies represents
an even greater risk to patient safety and public health as
this enterprise is largely populated by criminal actors,
websites are unregulated and lack required licensure for
operation, and eDTCA content often consists of mislead-
ing or fraudulent information directly targeted at the pa-
tient [13,17]. Indeed, illicit online pharmacies have been
found to market a wide array of pharmaceutical products
including those subject to critical shortages, vaccines, non-
communicable disease medicines, essential medicines, and
controlled substances to vulnerable patient populations
with limited access and resources [30-34]. These illegal
vendors use a variety of means to induce illicit purchases,
but, as most research suggests, the majority focus on “no
prescription required” approaches that represent the
highest risk to consumers [13-15,19].
Harm to prospective consumers sourcing medicines
from illicit no prescription online pharmacies comes in
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diagnosing and self-prescribing of their health conditions
without partnership of a medical professional [19]. This
behavior can lead them to purchase medications that are
unnecessary, have contraindications, have abuse poten-
tial or may otherwise be dangerous to their health even
in instances of sourcing authentic product [19,31]. Second,
even if a patient appropriately self-diagnoses their condi-
tion, purchasing from an illicit online pharmacy provides
no guarantee of quality or safety and can lead to the con-
sumption of counterfeit medicines that are substandard or
otherwise dangerous [19].
In this discussion, we focus on the illegal online mar-
keting and sale of any medication without a prescription,
which is a clear violation of laws and regulations of the
vast majority of countries requiring controls for dispens-
ing of regulated medical products. We focus on this pre-
dominant subset of online pharmacies as the quality and
safety of medications sourced from “no prescription”
websites largely cannot be determined, and even if there
is the possibility of sourcing authentic medication, pa-
tients may nevertheless be exposed to safety risks as pre-
viously described. Specifically, the Internet poses unique
challenges to counterfeit detection in that purchasing is
difficult to trace, and testing products illegally sourced
by individual online consumers is inherently difficult, in-
trusive and costly. Hence, false and misleading market-
ing utilized by no prescription online pharmacies can
induce the unregulated and illegal sale of medications of
unknown quality, with the consumer having no way of
ensuring what they are sourcing is safe [19].
These collective challenges have resulted in a general
lack of data needed to identify the exact percentage of
counterfeit medicines sold by illicit online pharmacies.
However, documented patient injury and deaths in mul-
tiple countries directly associated with online medicines
purchasing involving both substandard medications and
authentic medicine taken incorrectly provides a clear in-
dication of ongoing patient safety risks justifying regula-
tion and enforcement [19,22]. Further, increased online
self-prescribing behavior in combination with a recent
USA Food and Drug Administration (“FDA”) reporting
that 23% of adult Internet consumers purchased a pre-
scription medication online (which could include both
legitimate and illicit providers), provides a clear indica-
tion that additional research is needed to adequately de-
termine the scope of this problem [35].
Despite lack of comprehensive data, organizations such
as the USA National Association of Boards of Pharmacy
(“NABP”) have attempted to analyze how widespread is the
practice of illegal online marketing and operation of illicit
online pharmacies. In March, 2013, NABP released its
study of approximately 10,000 websites, reporting 97% of
them did not meet adequate pharmacy laws and practicestandards and 86% of these not requiring a valid prescrip-
tion [36]. This most recent assessment by the NABP re-
veals that there has not been a reduction in the presence of
illicit and “no prescription” providers [36,37]. An earlier
World Health Organization (“WHO”) report also esti-
mated that greater than 50% of websites failing to disclose
their physical address are engaged in the sale of counterfeit
medicines [38].
In addition, increasingly Medicine 2.0 or social media
forms of eDTCA have been identified as a platform for
the promotion of illicit online pharmacies [13,17]. This in-
cludes the use of popular social media sites of Facebook
and Twitter that have widespread global adoption [13]. A
recent study examined the vulnerabilities associated with
popular Medicine 2.0 technologies, and found that illicit
“no prescription” eDTCA promotion by a fictional online
pharmacy was easily accessible and reached a number
of global users in diverse countries, including developed
countries, low-and-middle income countries (“LMICs”),
as well as certain emerging “BRIC” countries (i.e., Russia
and China) [17].
Governance and cybercrime challenges of online
pharmacies
Although there is potential for harm from both legal
industry-based and illicit online pharmacy eDTCA, illicit
online marketing activity should be prioritized in global
health and Internet governance efforts. There is, for the
most part, no domestic means to ensure accountability
for illegal and harmful actions by these criminal actors
originating across geopolitical lines [14,19]. Practically
speaking, even assuming there are empowering applicable
laws, online pharmacies having a physical or infrastructural
presence outside of a nation’s jurisdiction may not be
reachable to regulate or police, compared with legal com-
panies that are multi-national and accountable to regula-
tory mandates [14,19,20,39]. In comparison, illicit online
pharmacies completely bypass domestic criminal laws, na-
tional medicines regulatory systems, local law enforcement,
and traditional public health access controls (e.g., pro-
tecting children and adolescents), since they are virtual,
easily anonymized, and market and sell directly to con-
sumers outside professional medical oversight [15,19,20].
The global vacuum of effective governance and regula-
tory approaches against illicit online pharmacies has pre-
dictably attracted large criminal networks looking to
profit from this trade. Consequently, illicit online phar-
macies threaten state sovereignty and global security due
to their association with transnational organized crime
syndicates, as well as cybercrime and cybersecurity threats
[20]. For example, in one prosecuted case, the Russian
Mafiya used online pharmacy distribution, massive email
spam, and introduction of computer viruses to produce
greater than $150 million in profits from illicit online
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Yet this is a case of successful detection and prosecution
in a digital environment where the majority of pharma-
ceutical crime often goes undetected. This continued ex-
pansion of pharmaceutical cybercrime is evident in the
continued proliferation of illicit online pharmacies and
their increasing use of various forms of eDTCA. eDTCA
use includes spam and other solicitations that act as a ve-
hicle for fraud, phishing scams, viruses, malware, and spy-
ware, often targeted towards vulnerable consumer groups
[15,19]. Indeed, close to 1/3rd of spam messages are health-
related, generally eDTCA originating from suspect online
pharmacies [41].
Internet pharmacy governance and enforcement
efforts
A wide array of public health and law enforcement
stakeholders, including WHO, the UN Office of Drugs and
Crime (“UNODC”), the International Criminal Police
Organization (“Interpol”), the FDA, NAPB, the USA Fed-
eral Bureau of Investigation, the International Pharmaceut-
ical Federation, the European Federation of Pharmaceutical
Industries and Associations, the Pharmaceutical Research
and Manufacturers of America, the Generic Pharmaceut-
ical Association, the Pharmaceutical Security Institute and
numerous other public and private sector groups have spe-
cifically recognized the global challenges posed by the
Internet and illicit online pharmacies [19,22,42-44]. Yet
few solutions have emerged to confront this form of glob-
alized pharmaceutical cybercrime.Figure 1 The illicit online pharmacy ecosystem.Further, strategic approaches are complicated given the
unclear applicability of domestic laws and general lack of
enforcement in the Internet service sector. For example,
although this criminal activity is perpetrated by a host of
clearly criminal actors (e.g., illegal manufacturers, orga-
nized crime, illicit online pharmacies), others, including
Internet Service Providers (e.g., search engines, social
media platforms, hosting companies, payment proces-
sors, affiliate sites, transportation companies, etc.), enable
illicit online pharmacy operations but often span multiple
jurisdictions and legal regimes (including those that may
be exempt from liability) [19-21,44] (See Figure 1). This
patchwork of various illicit and legal actors makes it diffi-
cult to detect, prevent and engage in enforcement efforts
against illicit online pharmacies at the domestic level,
consequently requiring global coordination and cooper-
ation that is elusive without effective multistakeholder
governance [20,22].
Below we identify some of the current global govern-
ance efforts attempting to address illicit online pharmacy
regulation at the national government level, voluntary gov-
ernance mechanisms addressing the promotion of pharma-
ceuticals, and global law enforcement efforts taken against
illicit online pharmacies.
Sovereign regulatory efforts
Legislative responses from national governments to ad-
dress the proliferation of illegal online pharmacies and
their eDTCA have been largely absent. Though sovereign
drug regulatory authorities usually regulate prescription
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mortar pharmacies, most have failed to regulate online
pharmacies as a distinct category [15,19]. For example, a
recent Member State survey by the WHO Global Observa-
tory for e-Health (“GOe”) found 66% of respondents had
no legislation either explicitly allowing or prohibiting Inter-
net pharmacy operations [15]. Of those countries regulat-
ing online pharmacies, only 19% prohibited this practice,
and indeed, 7% allowed it without adequate law enforce-
ment considerations [15].
Importantly, developing countries, with fewer resources,
were more likely to be silent on regulation of this public
health risk [15]. Indeed, the vast majority of respondents
(86%) did not regulate, accredit, or certify Internet phar-
macy sites, and 75% had no regulations permitting or pro-
hibiting the online purchasing of pharmaceuticals from
other countries, a practice which has already been identi-
fied as creating significant and demonstrable health risks
[15]. Even among the few countries that prohibit online
medicine foreign sourcing, only 20% of this group had spe-
cific law enforcement consequences [15].
Even if a country has enacted specific legislation, such
efforts may be inadequate and outdated to effectively
deal with the rapidly changing pace of the Internet en-
vironment. As an example, the USA, which has a strong
drug regulatory regime and extensive technological ac-
cess, enacted the Ryan Haight Online Pharmacy Consumer
Protections Act in 2008, regulating the online sale of con-
trolled substances [19,44]. Yet on closer inspection, this
law has significant limitations.
For example, the Act is limited in scope to only USA
Drug Enforcement Administration scheduled controlled
substances, which does not adequately cover the host of
medication therapeutic classes currently sold illicitly
over the Internet [45]. It also limits its oversight to illicit
sellers located in the USA, despite the observation that
the bulk of these illicit marketers and sellers are outside
the country [45]. Further, there appear to be no success-
ful prosecutions under the Act and reports by Internet
monitoring companies indicate that illicit online phar-
macies marketing the “no prescription” sale of controlled
substances continue to operate despite passage of the
law [46].
Voluntary governance mechanisms
There have also been voluntary guidelines issued to ad-
dress DTCA and other form of medicines promotion.
For example, the WHO Ethical Criteria for Medicinal
Drug Promotion (“WHO Criteria”) provides basic aspir-
ational tenets [47]. While these criteria were focused on
legitimate actors, principles contained therein are rele-
vant to current illicit online pharmacy promotional ac-
tivities. These guidelines indicate that DTCA medicines
promotion should: (a) be reliable, accurate and truthful;and (b) not contain misleading statements or omissions
that would give rise to risk [47].
Despite their seeming uncontroversial, foundational
nature, decades after introduction of the WHO Criteria,
WHO surveys have found a large fraction (~1/3rd) of coun-
tries have little to no regulatory oversight over pharma-
ceutical promotion [48,49]. Further, even more concerning,
even fewer countries have adequate capacity or resources
to regulate either licit or illicit pharmaceutical promotion
[48,49], exposing their populations to public health and in-
dividual patient safety harms associated with DTCA and
eDTCA.
Crucially, the WHO Criteria also fail to specifically ad-
dress emerging challenges of the Internet as a medium
for promotion and influencing health behavior. Further,
its voluntary nature highlights certain global govern-
ance limitations in regulating marketing by illicit online
pharmacies as guidelines only hold potential influence
over good faith actors, not criminal actors who dominate
this space. In this regard, other efforts, such as the NGO
HealthOntheNetFoundation Code of Conduct recom-
mending websites voluntarily adhere to certain principles
and undergo certification to ensure quality of online health
information, may also be limited in effectiveness and lack
applicability to online pharmacies [15].
Other voluntary efforts are marginally better because
they identify specific, legitimate online pharmacies that
have undergone credentialing and necessary domestic in-
spection requirements. For example, credentialing agen-
cies partnering with national drug regulators, such as
NABP and the Royal Pharmaceutical Society of Great
Britain, have created their own programs as well as main-
tain lists of websites that they have identified as highly
suspect [15,19,37]. The European Parliament has also
attempted to specifically address illegal Internet medicine
sales through issuing Directives aimed at developing
enforcement measures and differentiating illicit actors
from legitimate sources by using credentialing and a com-
mon logo [50]. However, participation in these programs
has been limited, and consumers have limited knowledge
of the value of these programs in engaging in online sour-
cing behavior.
Global law enforcement efforts
Although national online pharmacy legislation and vol-
untary governance initiatives attempting to regulate global
pharmaceutical promotion have been limited in effective-
ness, criminal law enforcement efforts have shown prom-
ise. These largely field-based operations have targeted the
shut down of illicit online pharmacies and are coordinated
by international organizations such as Interpol and the
UNODC.
In fact, recently, Interpol, the world’s largest inter-
national police organization, announced a comprehensive
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crime in cooperation with 29 of the world’s largest
pharmaceutical companies [51]. This investment in on-
line pharmacy cybercrime prevention includes the recent
“Operation Pangea VI”, a multi-stakeholder initiative in-
volving law enforcement, the pharmaceutical and whole-
saler industries, the Internet service sector, credit card
companies, health regulators and customs agencies co-
operating to target enforcement against illicit online drug
sellers [52]. Operation Pangea VI resulted in a reported
9.8 million potentially dangerous medicines confiscated
(at an estimated worth of USD$41 million), shut down of
greater than 9,000 websites, and arrested or placed under
investigation 58 individuals around the world [52]. This
represents a marked increase in online enforcement ac-
tivity since Operation Pangea II in 2009, which reported
shut down of 153 websites and 12 arrests/individuals under
investigation [53].
UNODC has also taken an active role in the global
fight against transnational organized crime involved in
the trafficking of counterfeit medicines [54]. This in-
cludes partnership with the International Narcotics Con-
trol Board, which has specifically called upon governments
to engage in enforcement against illicit online pharmacies
[55]. This partnership also included an emphasis on en-
forcement and prevention of online pharmacy use of social
media marketing to target youth and children, one of
the few times there has been international recognition
of the emerging threat of illicit eDTCA use in Medicine
2.0 technologies [55].
Despite Interpol and UNODC-led efforts, lack of a
sustained and internationally agreed upon multilateral/
multistakeholder mechanisms for proactive identification,
prevention, and enforcement against illicit online phar-
macies persists. Global coordination is limited, allowing
these virtual criminal actors to remain active worldwide
and continually create new illicit eDTCA and cyber-
pharmacies. Though limited in effectiveness, Operation
Pangea represents a potentially successful model of part-
nership and collaboration among the wide range of stake-
holders necessary to address this problem and can be
built upon strategically for future efforts. Indeed, without
multi-lateral/sector cooperation, it is simply impossible
to target and disable all relevant technologies supporting
illicit online pharmacies [20].
Other public private partnership models (“PPPs”) have
also been tried as potential governance mechanisms be-
yond Interpol’s Operation Pangea. For example, the Alli-
ance for Safe Online Pharmacies and Center for Safe
Internet Pharmacies are attempting to coordinate efforts
addressing marketing and sales by illicit online pharma-
cies in the USA [44,56,57]. In addition, countries such as
China have also engaged in public-private collaboration,
recently forming a partnership between Chinese searchengine Baidu and the State Food and Drug Administration
to provide online certification and search results identifying
legitimate online pharmacies [58]. The effectiveness of
these programs remains to be seen; however, without
investment and tangible mechanisms to enable action and
coordination across geopolitical lines, their effectiveness to
address the complexity of the online pharmacy problem is
questionable.
Global health and internet governance
Our examination of governance efforts indicates that na-
tional government legislation, voluntary governance mech-
anisms, and global law enforcement efforts attempting to
address the public health and cybersecurity risks of illicit
online pharmacies have not been adequate, especially in
the context of unregulated eDTCA. Illicit online pharmacy
eDTCA use explicitly involves criminal actors that utilize
false and misleading information meant to induce unjusti-
fied and unsafe use of medicines. These concerns clearly
reside within the general principles of ethical standards
enshrined in the WHO Criteria targeting industry-based
promotion, yet which did not anticipate the development
of illicit online pharmacies as a point of access and source
of promotion. Further, even if the WHO Criteria had spe-
cifically addressed illegal online pharmacy promotion in its
text, lack of adoption of its guidelines in national legislation
would continue to limit effectiveness of its application. Im-
proved global health and Internet governance is therefore
urgently needed.
Illicit global trafficking of medicines via the Internet
directly impacts individual patients and population-based
health outcomes. Yet infrastructures enabling this illicit
e-commerce are primarily IT and private sector driven
[19,20]. Consequently, although a public health con-
cern, combatting it must engage specialized partners
to reflect the criminal nature of the perpetrators, global
networks of conspirators, technical nature of the crime,
and health harms that ensue from these illicit activities.
An effective solution begins with enhanced and inclusive
governance mechanisms engaging multidisciplinary ac-
tors from global public health, but also IT and law en-
forcement entities empowered to fight transnational
organized forms of cybercrime. Leveraging existing Inter-
net and health governance structures, raising awareness
to this form of cybercrime, and creating a new paradigm
for “e-Health Governance” can form the foundation for
this strategy.
Evolving internet governance
“Internet governance” is a relatively new phenomena.
Conceptually, it is defined as the establishment of shared
principles, norms, rules, decisionmaking procedures
and programs developed by governments, the private
sector, and civil society on the use and evolution of
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multi-stakeholder, multi-country, interconnected, self-
governed and autonomous group of actors, the UN has
made Internet governance a global priority despite its
highly challenging nature.
Beginning in 2005, the UN-initiated World Summit on
the Information Society (“WSIS”) established the Inter-
net Governance Forum (“IGF”) to engage, in an open
and inclusive manner, multiple stakeholders in a policy
dialogue regarding Internet governance [60]. Importantly,
IGF led to inclusion of an expanding set of international
Internet policy issues for debate. Originally, Internet
governance focused narrowly on technical aspects (i.e.,
protocols, infrastructure) but now has evolved to include
international policy development on issues such as secur-
ity, stakeholder information exchange and engagement,
and, crucially, finding solutions to issues arising from the
misuse of the Internet [61].
IGF has been successful in engaging a wide array of
stakeholders, including national governments, the private
sector, civil society, academia, and other technical com-
munities [61]. Importantly, these include public health,
law enforcement, and Internet experts/groups such as
ICANN, Interpol, ITU, WHO, the World Wide Web
Consortium, Council of Europe (which has its own treaty,
the MEDICRIME Convention, the first binding inter-
national instrument addressing the counterfeiting of
medical products and similar crimes involving threats
to public health from a criminal law standpoint [62]),
Hewlett-Packard (which has developed its own mPedigree
mobile medicines authentication system), and numerous
others [63].
As a UN Summit, WSIS is relatively flexible, allowing
primary agenda setting by UN Member States, broad en-
gagement with other UN agencies, while intergovern-
mental organizations, accredited civil society and private
sector entities, and other associated entities can partici-
pate as observers [60]. However, IGF’s structure is much
more developed and inclusive, with a Multistakeholder
Advisory Group comprised of members from national
governments, civil society, the private sector, as well as
academic and technical communities that provide infor-
mation to the UN Secretary General on programmatic
activities [64].
A foundational proposal: e-health governance
for cybercrime
Extant Internet governance approaches are very useful
in addressing online health activities. WSIS and IGF’s
structures and the WSIS plan of action have stated goals
of building an “inclusive Information Society” promoting
international and regional cooperation, incorporating
public-private partnership (“PPP”) models into its action
plans, promoting e-Health technologies and quality ofonline health information, and expressly noting the need
to take appropriate measures to combat illegal and harm-
ful media content [65].
Building upon emerging Internet governance, we
believe an enhanced “e-Health Governance” model for
cybercrime can be created, beginning a coordinated and
focused effort to address illicit online pharmacies and
their fraudulent and misleading use of eDTCA. Foun-
dationally, this would entail promoting global health
diplomacy efforts in all Internet governance activities, con-
sistently prioritizing illicit online pharmacies as a preemi-
nent cybersecurity and cybercrime issue, and building
protections so that eDTCA is not false or misleading for
consumers.
Proposed e-Health Governance for cybercrime should
be shaped like the more inclusive IGF infrastructure and
include its broad membership. This is both most ac-
ceptable and apt, as IGF stakeholders have already begun
discussions regarding eDTCA regulation, counterfeit medi-
cines in developing countries, pharmaceutical authentica-
tion technologies, and fraudulent commercial practices of
illicit online pharmacies in the context of subjects regard-
ing international trade, privacy and security, digital access,
and improving Internet governance [66-68]. IGF is an ex-
tant, well-established, functional, and broadly competent
group that can garner efficiencies as well as avoid limita-
tions of existing governance mechanisms that fail to engage
necessary and broader stakeholder participation [22].
However, beyond IGF infrastructure and membership,
crucial to the success of e-Health cybercrime governance
is partnership with organizations that currently focus on
illicit online pharmacy networks, transnational crime, and
cybersecurity. Here, the UNODC is well situated to coord-
inate IGF partner efforts. First, UNODC is the lead UN
agency combatting global organized criminal networks,
including trade in counterfeit medicines. Importantly, it
has widespread political support and existing partnerships
with organizations such as Interpol, the World Customs
Organization and civil society that are already active in the
fight against counterfeit medicines [22].
Second, UNODC is empowered by the UN Conven-
tion against Transnational Organized Crime (“UNTOC”)
[22,69,70]. UNTOC allows UNODC to address serious
global crimes, including human trafficking, smuggling,
and illicit manufacture and trafficking of dangerous ma-
terials [69]. UNTOC also has near universal global adop-
tion; 174 Member States are party to the Convention.
Under UNTOC, UN Member States commit themselves
to enact domestic laws against organized crime and collab-
orate internationally to fight against criminal networks.
UNODC and application to UNTOC have recently
converged regarding illicit online pharmacy and fraudu-
lent eDTCA cybercrime–focused issues. At the 2011 20th
Session of UN Commission on Crime Prevention and
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adopted that clearly have reinforced global empowerment
of UNODC to fight illicit online pharmacy activities:
Resolution 20/4, “Promoting further cooperation in coun-
tering transnational organized crime,” Resolution 20/6,Table 1 Fundamentals of UNODC-IGF e-health governance on
Area of focus Description Goals
e-Health security Dynamic Coalition Working Group (DCWG)
in IGF comprised of stakeholders from









Development of special Multistakeholder
Advisory Group (MAG) of IGF with
permanent membership that advises











Development of a structured mechanism
to engage multiple public and private
stakeholders to form public-private
partnership (PPP) models addressing














DCWG or MAG will review and explore
the merits of existing online credentialing






Cybercrime tools DCWG and PPPs jointly working together
to develop technical capacity and
necessary tools for cybercrime surveillance,









online pha“Countering fraudulent medicines, in particular their traf-
ficking” (“fraudulent” medicines defined by the CCPCJ as
those whose contents are inert, expired, or otherwise
different from what indicated,) and Resolution 20/7,
“Promotion of activities relating to combating cybercrime,cybercrime
Activities
“best practices” or similar agreed
f recommendations regarding
curity and access specifically
needs of global public health
ting Internet pharmacies.
Development of a living document that
should be revisited as experience in
cybercrime grows in the health sector.
The primary issue for this working
group to address is ensuring patients
with safe and quality access to health
information and services online,
including appropriately regulating
eDTCA and Internet pharmacies.
F MAG would raise awareness
e in health diplomacy regarding
naddressed areas of transnational
involving health, specifically
g cybercrime and public health
it online pharmacies.
MAG should participate in and advocate
for e-Health Governance issues in future
WSIS regional preparatory meetings,
WSIS + 10 High Level Meeting in 2014,
and Overall Review of the
Implementation of WSIS Outcomes in
2015, focusing on the serious public
health and cybersecurity concerns from
illicit online pharmacies.
nd investment in PPP pilot
ecifically addressing cybercrime
d by illicit online pharmacies.
icipation of UNODC, Interpol,
branded and generic
tical and wholesaler industries,
t service sector, patient safety
al professional societies, as well
akeholders should be sought
.
PPPs in global health have come
under scrutiny regarding the need for
transparency and mitigating conflicts
of interest. However, PPPs in Internet
governance have generally not been
subject to the same scrutiny as private
sector participation is essential and
necessary in the operation and
maintenance of the Internet. Hence,
PPPs in the Internet governance fora
that focus on cybercrime can provide
a sustained pathway for collective
action/enforcement and continued
investment.
ent and deployment of a
armonized credentialing
t is easy for consumers to
d and use for purposes of
medications online.
The NABP VIPPS program as well as
proposed EU systems should be
assessed and determination of a
potential global standard considered.
Use of other third party Internet
surveillance companies should also be
explored. Other alternatives that
promote easy consumer verification
of legitimate entities should also be
explored such as creation of monitored
and accredited generic top-level-domain
names and investment in programs to
increase digital health literacy.
f its unique technical expertise
Internet governance and
al organized crime, UNODC-IGF
ntify and incorporate current
surveillance, prevention,
cation and enforcement
nto effective tools against illicit
rmacies.
Joint development of technologies to
proactively detect and remove online
content using web crawlers/spiders,
anti-spam filters, IP blocking, suspension
of electronic financial transactions/
processing, domain name server
monitoring and surveillance, fraud
detection tools, as well as other
strategies to combat illicit online
pharmacies and their fraudulent
eDTCA marketing.
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Each contemplates and calls for UNODC leadership based
on its unique capabilities, empowerment, transnational ex-
perience and/or its successful, inclusive partnerships with
other stakeholders.
Leveraging its support and empowerment, UNODC can
engage IGF and WSIS stakeholders to promote e-Health
Governance investigation, detection, and coordination
activities against illicit online pharmacies and their mis-
leading eDTCA. Further, a UNODC-IGF partnership infra-
structure can spearhead additional legal and enforcement
capacity by creating model national legislation to address
criminal oversight of online pharmacies, particularly given
the current absence of regulatory development in the vast
majority of countries worldwide [15].
Once established, several matters could be on its early
agenda. We believe five fundamental matters should be
addressed as permanent agenda items in UNODC-led
e-Health Governance efforts focusing on illicit online
pharmacy related cybercrime. They focus upon security,
diplomacy, partnerships, credentialing, and criminal sur-
veillance strategies (see Table 1). Through this infra-
structure and permanent agenda, dynamically adjusted as
technology evolves, a UNODC-IGF e-Health Governance
solution for cybercrime can begin the process of creating
effective legal and technical barriers against illicit online
pharmacies and their fraudulent eDTCA use.
Conclusions
As illicit online pharmacies continue to proliferate and
target patients globally with misleading and fraudulent
forms of eDTCA, multistakeholder-based governance ef-
forts must be created to effectively address this danger-
ous form of cyber and public health crime. The focus of
any eHealth Governance approach must be on ensuring
appropriate competencies and leadership are included,
leveraging of resources, and the coordination and co-
operation between the public health, IT, and the law en-
forcement international community. Using UNODC in
combination with IGF provides such an opportunity. It
is essential that the global community act collaboratively
to address the unprecedented threat posed by illicit on-
line pharmacies and their unregulated use of eDTCA. By
promoting health and security in all forms of Internet
governance, eHealth Governance systems can develop
dynamically to ensure global patients are safe from dan-
gerous, misrepresented medicines online today, tomor-
row, and for future generations to come.
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